GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Womens Health Inc (FRA:CUL) » Definitions » 5-Year Yield-on-Cost %

Aspira Womens Health (FRA:CUL) 5-Year Yield-on-Cost % : 0.00 (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Aspira Womens Health 5-Year Yield-on-Cost %?

Aspira Womens Health's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Aspira Womens Health's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:CUL's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.37
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Aspira Womens Health's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Aspira Womens Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspira Womens Health's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Aspira Womens Health's 5-Year Yield-on-Cost % falls into.



Aspira Womens Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Aspira Womens Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Aspira Womens Health  (FRA:CUL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Aspira Womens Health 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Aspira Womens Health's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspira Womens Health (FRA:CUL) Business Description

Traded in Other Exchanges
Address
12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician's independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.

Aspira Womens Health (FRA:CUL) Headlines

No Headlines